258 HORIZON-01: a phase I–III platform study evaluating the efficacy and safety of multiple therapies in patients with biomarker-defined locally advanced, unresectable stage III non-small cell lung cancer (NSCLC). - Sanjay, Popat; Adam, Januszewski; Laura, Cove-Smith; Shobhit, Baijal; Georgios, Imseeh; Carl, Gay; Keith, Kerr; Terufumi, Kato; Luis, Paz-Ares; Caicun, Zhou; Karl, Redhead; Elizabeth, Theogaraj; et al. (Lung Cancer (01695002), 2025)